(AGENPARL) – WORCESTER (MASSACHUSETTS), lun 07 giugno 2021 (Fundação de Amparo à Pesquisa do Estado de São Paulo) Researchers used protein mapping to show how abnormal levels of the neurotransmitter glutamate impair the functioning of neurons and oligodendrocytes. The findings could serve as a basis for more effective treatment.
Fonte/Source: https://www.eurekalert.org/pub_releases/2021-06/fda-sht060721.php
Essa notícia também repercutiu nos veículos:
LaptrinhX
Learn Teeth Whitening
Knowledia (França)
The World News (EUA)
Psychiatric Enlightenment
Detonic
Science News Net
Press-news.org
Medical Xpress (Reino Unido)
MediExpose (ìndia)
4State News
Awebfind.biz
ECIS Tech
News Medical (Austrália)
International Business Times (Singapura)
The Medical Dispatch
Biotech Asia News (Índia)
Top Personal Health
Scienmag Science Magazine (Reino Unido)
Science Codex
7thSpace
Bioengineer (Reino Unido)
King firth Health and Fitness
Worlds Family Medicine
Polymerelektronik.org